XML 44 R30.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Financial Instruments and Risk Management (Tables) | 3 Months Ended
--- | ---
Mar. 30, 2024
Disclosure Financial Instruments and Risk Management [Abstract] |
Schedule of Notional Amounts of Outstanding Derivative Positions |
| Hedge Type |  | March 30, 2024 |  | December 30, 2023
U.S. dollar equivalent notional amount of derivative instruments: |  |  |  |  |
Forward foreign exchange contracts | Cash Flow and Mark to Market |  | $ | 272,313 |  |  | $ | 308,760 |
Interest rate contracts | Cash Flow |  | $ | 900,000 |  |  | $ | 900,000 |
Fair Values of Derivative Instruments | The fair values of derivative instruments related to forward foreign exchange contracts and interest rate contracts recognized in the Condensed Consolidated Balance Sheets of the Company were as follows:
| Balance Sheet Location |  | Fair Value
| March 30, 2024 |  | December 30, 2023
Derivatives designated as hedging instruments: |  |  |  |  |
Forward foreign exchange contracts | Other current assets |  | $ | 2,354 |  |  | $ | 57 |
Interest rate contracts | Other current assets |  | 23 |  |  | 23 |
Forward foreign exchange contracts | Other noncurrent assets |  | 117 |  |  | — |
Interest rate contracts | Other noncurrent assets |  | 2,250 |  |  | — |
Derivatives not designated as hedging instruments: |  |  |  |  |
Forward foreign exchange contracts | Other current assets |  | 2,789 |  |  | 142 |
Total derivative assets |  |  | 7,533 |  |  | 222 |
Derivatives designated as hedging instruments: |  |  |  |  |
Forward foreign exchange contracts | Accrued liabilities |  | (454) |  |  | (2,508) |
Forward foreign exchange contracts | Other noncurrent liabilities |  | (3) |  |  | (290) |
Interest rate contracts | Other noncurrent liabilities |  | — |  |  | (5,929) |
Derivatives not designated as hedging instruments: |  |  |  |  |
Forward foreign exchange contracts | Accrued liabilities |  | (555) |  |  | (2,784) |
Total derivative liabilities |  |  | (1,012) |  |  | (11,511) |
Net derivative asset (liability) |  |  | $ | 6,521 |  |  | $ | (11,289) |
Effect of Cash Flow Hedge Derivative Instruments | The effect of derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations and AOCI is as follows:
| Amount of Gain (Loss) Recognized in AOCI on Derivative Instruments |  |
| Quarters Ended |  |  |  |
| March 30, 2024 |  | April 1, 2023 |  |  |  |  |  |
Forward foreign exchange contracts | $ | 5,499 |  |  | $ | (72) |  |  |  |  |  |  |
Interest rate contracts | 10,275 |  |  | (14,674) |  |  |  |  |  |  |
Cross-currency swap contracts | — |  |  | (2,865) |  |  |  |  |  |  |
Total | $ | 15,774 |  |  | $ | (17,611) |  |  |  |  |  |  |
| Location of Gain (Loss) Reclassified from AOCI |  | Amount of Gain (Loss) Reclassified from AOCI into Net Income (Loss)
|  | Quarters Ended |  |
|  | March 30, 2024 |  | April 1, 2023 |  |  |  |
Forward foreign exchange contracts(1) | Cost of sales |  | $ | 2,543 |  |  | $ | 3,410 |  |  |  |  |
Interest rate contracts | Interest expense, net |  | 2,096 |  |  | 10 |  |  |  |  |
Cross-currency swap contracts(1) | Selling, general and administrative expenses |  | — |  |  | 973 |  |  |  |  |
Cross-currency swap contracts(1) | Interest expense, net |  | — |  |  | 581 |  |  |  |  |
Total |  |  | $ | 4,639 |  |  | $ | 4,974 |  |  |  |  |
(1)The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value. The following table presents the amounts in the Condensed Consolidated Statements of Operations in which the effects of cash flow hedges are recorded:
| Quarters Ended |  |
| March 30, 2024 |  | April 1, 2023 |  |  |  |
Cost of sales | $ | 695,274 |  |  | $ | 939,717 |  |  |  |  |
Selling, general and administrative expenses | $ | 408,821 |  |  | $ | 392,374 |  |  |  |  |
Interest expense, net | $ | 66,689 |  |  | $ | 58,452 |  |  |  |  |
Effect of Net Investment Hedge Derivative Instruments | The amount of after-tax gains (losses) included in AOCI in the Condensed Consolidated Balance Sheets related to derivative instruments and nonderivative financial instruments designated as net investment hedges are as follows:
| Amount of Gain (Loss) Recognized in AOCI
| Quarters Ended |  |
| March 30, 2024 |  | April 1, 2023 |  |  |  |
Euro-denominated long-term debt | $ | — |  |  | $ | (469) |  |  |  |  |
Cross-currency swap contracts | — |  |  | 531 |  |  |  |  |
Total | $ | — |  |  | $ | 62 |  |  |  |  |
The effect of derivative instruments designated as net investment hedges on the Condensed Consolidated Statements of Operations are as follows:
| Location of Gain (Loss) Reclassified from AOCI |  | Amount of Gain (Loss) Reclassified from AOCI into Net Income (Loss)
|  | Quarters Ended |  |
|  | March 30, 2024 |  | April 1, 2023 |  |  |  |
Cross-currency swap contracts (amounts excluded from effectiveness testing) | Interest expense, net |  | $ | — |  |  | $ | 960 |  |  |  |  |
The following table presents the amounts in the Condensed Consolidated Statements of Operations in which the effects of net investment hedges are recorded:
| Quarters Ended |  |
| March 30, 2024 |  | April 1, 2023 |  |  |  |
Interest expense, net (amounts excluded from effectiveness testing) | $ | 66,689 |  |  | $ | 58,452 |  |  |  |  |
Effect of Mark to Market Hedge Derivative Instruments | The effect of derivative instruments not designated as hedges on the Condensed Consolidated Statements of Operations is as follows:
| Location of Gain (Loss) |  | Amount of Gain (Loss) Recognized in Net Income (Loss)
| Quarters Ended |  |
| March 30, 2024 |  | April 1, 2023 |  |  |  |
Forward foreign exchange contracts | Cost of sales |  | $ | 4,021 |  |  | $ | (2,260) |  |  |  |  |
Forward foreign exchange contracts | Selling, general and administrative expenses |  | — |  |  | 848 |  |  |  |  |
Total |  |  | $ | 4,021 |  |  | $ | (1,412) |  |  |  |  |

X
- Definition Disclosure Financial Instruments and Risk Management + References No definition available. + Details
Name: | hbi_DisclosureFinancialInstrumentsAndRiskManagementAbstract
Namespace Prefix: | hbi_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Effect of mark to market hedge derivative instruments on the condensed consolidated statements of operations. + References No definition available. + Details
Name: | hbi_EffectOfMarkToMarketHedgeDerivativeInstrumentsOnCondensedConsolidatedStatementsOfOperationsTableTableTextBlock
Namespace Prefix: | hbi_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C + Details
Name: | us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the notional amounts of outstanding derivative positions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A + Details
Name: | us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration